Caveolin-1 contributes to realgar nanoparticle therapy in human chronic myelogenous leukemia K562 cells

Caveolin-1 contributes to realgar nanoparticle therapy in human chronic myelogenous leukemia K562 cells

Dan Shi,1,* Yan Liu,1,* Ronggang Xi,1 Wei Zou,2 Lijun Wu,3 Zhiran Zhang,1 Zhongyang Liu,1 Chao Qu,1 Baoli Xu,1 Xiaobo Wang1 1Department of Pharmacy, The 210th Hospital of People’s Liberation Army, 2College of Life Science, Liaoning Normal University, Dalian, Liaoning, 3Department of Pharm...

Full description

Bibliographic Details
Main Authors: Shi D, Liu Y, Xi RG, Zou W, Wu LJ, Zhang ZR, Liu ZY, Qu C, Xu BL, Wang XB
Format: Article
Language:English
Published: Dove Medical Press 2016-11-01
Series:International Journal of Nanomedicine
Subjects:
realgar nanoparticles
Bcr-Abl fusion protein
apoptosis
autophagy
Caveolin-1
Online Access:https://www.dovepress.com/caveolin-1-contributes-to-realgar-nanoparticle-therapy-in-human-chroni-peer-reviewed-article-IJN

Internet

https://www.dovepress.com/caveolin-1-contributes-to-realgar-nanoparticle-therapy-in-human-chroni-peer-reviewed-article-IJN

Similar Items